What is the appropriate treatment for a patient with a two‑week history of resolved upper respiratory infection who now has a persistent, worsening cough with paroxysmal fits and occasional vomiting, a normal chest X‑ray, and no fever?

Treatment for Post-URI Persistent Paroxysmal Cough with Post-Tussive Vomiting

This patient requires immediate testing for pertussis (Bordetella pertussis) with nasopharyngeal culture or PCR, and empiric treatment with a macrolide antibiotic should be initiated while awaiting results, as the clinical presentation—paroxysmal cough with post-tussive vomiting lasting >2 weeks following URI—is diagnostic of pertussis until proven otherwise. 1

Diagnostic Approach

The clinical triad of:

• Cough >2 weeks duration
• Paroxysmal coughing fits
• Post-tussive vomiting (with or without inspiratory whoop)

should trigger a presumptive diagnosis of pertussis unless another cause is definitively proven 1. The normal chest X-ray and absence of fever support this diagnosis rather than bacterial pneumonia.

Confirmatory Testing

• Obtain nasopharyngeal aspirate or Dacron swab for culture - this is the gold standard for definitive diagnosis 1
• PCR testing is available but lacks standardized validation for routine clinical use 1
• Paired acute and convalescent sera showing fourfold increase in IgG or IgA antibodies to pertussis toxin (PT) or filamentous hemagglutinin (FHA) can provide presumptive diagnosis 1

Treatment Algorithm

If Pertussis is Confirmed or Highly Suspected:

1. Macrolide Antibiotic (First-Line)

• Initiate immediately—early treatment within the first few weeks diminishes coughing paroxysms and prevents disease spread 1
• Standard options: azithromycin, clarithromycin, or erythromycin 2, 3
• Critical caveat: Treatment beyond the early catarrhal/early paroxysmal stage is unlikely to alter the clinical course but still prevents transmission 1
• Isolate the patient for 5 days from start of antibiotic treatment 1

2. Treatments That Do NOT Work for Pertussis:

• Long-acting β-agonists: Grade D recommendation—do not use 1
• Antihistamines: Grade D recommendation—do not use 1
• Corticosteroids: Grade D recommendation—do not use 1
• Pertussis immunoglobulin: Grade D recommendation—do not use 1

If Pertussis is Ruled Out (Post-Infectious Cough):

This becomes a diagnosis of exclusion after negative pertussis testing. The treatment hierarchy is:

Step 1: Inhaled Ipratropium Bromide

• Grade B recommendation—first-line therapy for post-infectious cough 1
• Has demonstrated efficacy in attenuating post-infectious cough in controlled trials 1

Step 2: If Ipratropium Fails and Cough Severely Affects Quality of Life

• Add inhaled corticosteroids 1

Step 3: For Severe Paroxysms (After Ruling Out UACS, Asthma, GERD)

• Oral prednisone 30-40 mg daily for a short, finite period (2-3 weeks with taper) 1
• Grade C recommendation for severe paroxysmal post-infectious cough 1

Step 4: If All Else Fails

• Central-acting antitussives (codeine or dextromethorphan) 1

What NOT to Use:

• Antibiotics have no role in post-infectious cough (Grade I—expert opinion states no benefit) 1

Critical Clinical Pitfalls

Timing Matters for Pertussis Treatment

The guidelines emphasize that macrolide antibiotics are most effective when started in the first few weeks of illness (during catarrhal or early paroxysmal stage). Once the patient is in late paroxysmal stage (which this patient likely is at 2+ weeks), antibiotics may not alter the clinical course but still prevent transmission and should be given 1.

Don't Confuse with Bacterial Sinusitis

Viral rhinosinusitis commonly accompanies the common cold and shows sinus abnormalities on imaging in 87% of cases, but bacterial sinusitis cannot be accurately diagnosed in the first week of symptoms 4. This patient is beyond that window, but the paroxysmal nature with vomiting points more toward pertussis.

Duration Threshold

If cough persists >8 weeks, consider diagnoses other than post-infectious cough entirely 1. At 2 weeks with worsening symptoms, this patient is still within the post-infectious/pertussis window.

Rule Out Other Common Causes

Before treating as simple post-infectious cough, ensure you've considered:

• Upper airway cough syndrome (UACS) from rhinosinus disease
• Asthma (bronchial hyperresponsiveness is common post-viral)
• Gastroesophageal reflux disease (GERD)

These are the most common causes of persistent cough and may coexist 1.

Public Health Considerations

• Notify local public health department of suspected pertussis cases 5
• Identify and treat close contacts, especially high-risk populations (infants, pregnant women in third trimester, childcare workers) with post-exposure prophylaxis 2, 5, 3
• Household contacts may benefit from prophylactic macrolides 5

Emerging Resistance Concerns

Recent evidence from China shows high prevalence of erythromycin-resistant Bordetella pertussis (ERBP), which may lead to treatment failure with macrolides 6, 7. If macrolide resistance is suspected or confirmed:

• For children >2 months: oral trimethoprim-sulfamethoxazole 6
• For severe cases or sulfa allergy: IV piperacillin or cefoperazone-sulbactam 6

This is primarily a concern in specific geographic regions but worth considering if the patient fails to improve on macrolide therapy.